A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD

Treatments in Respiratory Medicine
James F DonohueKatharine Knobil

Abstract

This is the first comparison of two combination therapies, fluticasone propionate/salmeterol and ipratropium bromide/albuterol (salbutamol), for the treatment of patients with COPD. A randomized, double-blind, double-dummy, parallel group, multicenter evaluation of fluticasone propionate/salmeterol 250/50 microg twice daily via DISKUS and ipratropium bromide/albuterol 36/206 microg four times daily via metered-dose inhaler over 8 weeks was conducted at 41 research sites in the US. Morning pre-dose FEV(1), 6-hour serial spirometry, PEF, dyspnea, night-time awakenings, supplemental albuterol use, and patient diary evaluations of symptoms were evaluated. A total of 365 patients with symptomatic COPD were enrolled. The treatment groups were similar in mean age (63.3 and 63.9 years), screening pulmonary function (44.1% and 43.2% of predicted FEV(1)), race (96% and 95% White), and sex distribution (59% and 60% male). Both fluticasone propionate/salmeterol and ipratropium bromide/albuterol improved lung function, symptoms, and supplemental albuterol use compared with baseline. Fluticasone propionate/salmeterol was more effective than ipratropium bromide/albuterol for improvement in morning pre-dose FEV(1), morning PEF, 6-hour FEV(1) a...Continue Reading

References

Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·J N BaraniukT Troost
Apr 20, 1999·Chest·D A MahlerW H Anderson
Apr 24, 2001·American Journal of Respiratory and Critical Care Medicine·S I RennardK Rickard
Aug 14, 2001·American Journal of Respiratory and Critical Care Medicine·D B CoultasE Lydick
Mar 2, 2002·The European Respiratory Journal·W VinckenUNKNOWN Dutch/Belgian Tiotropium Study Group
Feb 14, 2003·Lancet·Peter CalverleyUNKNOWN TRial of Inhaled STeroids ANd long-acting beta2 agonists study group
Mar 1, 2003·The European Respiratory Journal·T J Witek, D A Mahler
May 3, 2003·Journal of Clinical Epidemiology·Theodore J Witek, Donald A Mahler
Dec 19, 2003·The European Respiratory Journal·P M CalverleyH Olsson

❮ Previous
Next ❯

Citations

Jan 28, 2006·American Journal of Respiratory and Critical Care Medicine·David M ManninoKourtney J Davis
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·K F Chung
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Paolo Montuschi
Feb 12, 2011·International Journal of Chronic Obstructive Pulmonary Disease·James F Donohue, Paul W Jones
Sep 12, 2014·International Journal of Chronic Obstructive Pulmonary Disease·David PriceKatsiaryna Bichel
Feb 19, 2010·Expert Opinion on Drug Metabolism & Toxicology·Joshiah Gordon, Ralph J Panos
Feb 24, 2009·Current Medical Research and Opinion·E Rand SutherlandKimberly Denis-Mize
Sep 26, 2006·The American Journal of Medicine·Andrew L Ries
Dec 14, 2006·Expert Opinion on Pharmacotherapy·Laura MeinkeGanesh Krishna
Oct 22, 2005·Respiratory Medicine·Nicola A HananiaBarry Make
Dec 9, 2009·Health and Quality of Life Outcomes·Robin F PokrzywinskiDennis A Revicki
Jun 8, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·C P Onno van Schayck, Jim Reid
Nov 12, 2013·The Cochrane Database of Systematic Reviews·Luis Javier NanniniRebecca Normansell
Apr 1, 2005·Nonlinearity in Biology, Toxicology, Medicine·Min An
Feb 23, 2020·NPJ Primary Care Respiratory Medicine·Ioanna Tsiligianni, Janwillem W H Kocks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.